Laura B. Monico, Ph.D.

Laura B. Monico, Ph.D.
Laura B. Monico, Ph.D.
Research Scientist

Ph.D., Sociology, University of Delaware
M.A., Sociology, University of Delaware
Phone: 410-837-3977 ext. 248
Fax: 410-752-4218
Research Interests

Dr. Monico specializes in health services research that aims to improve the quality of substance abuse treatment delivery for both adults and adolescents, specifically for those with opioid use disorders. She has been actively involved in data collection or analysis on a number of NIDA-funded studies that investigate various dimensions of pharmacotherapy, such as the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) Phase II initiative MATICCE study, Intensive Outpatient v. Outpatient Treatment with Buprenorphine among African Americans, Reengineering Methadone Treatment: A Clinical Trial, Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth, and A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail. In addition, she recently completed a dissertation that uses an ecological systems perspective to understand buprenorphine patients’ experience in an opioid treatment program. The results of this dissertation identified barriers for buprenorphine treatment entry, engagement, and retention, as well as contributed to a better understanding of prescription opioid initiation, progression of addiction severity, and the intersection of route of administration.

Selected Publications
Lounsbury DW, Mitchell SG, Dusek K, Li Z, Kirk AS, Oros M, Hosler C, Schwartz RP, Gryczynski J, Monico LB & Brown BS (in press). Application of System Dynamics Modeling to Inform Implementation of Adolescent SBIRT in Primary Care Settings. Journal of Behavioral Health Services & Research.
Mitchell MM, Gryczynski J, Mitchell SG, Kelly SM, O’Grady KE, Monico LB, Schwartz RP (in press). A Latent Class Analysis of HIV Risk Factors Among Men and Women with Opioid Use Disorder in Pre-trial Detention. AIDS and Behavior. 2019 Nov 20. doi: 10.1007/s10461-019-02726-y. [Epub ahead of print] PMID: 31748939.
Monico L, Ludwig A, Lertch E, Dionne R, Fishman M, Schwartz R, Mitchell S (in press). Adolescent and young adult opioid overdose experiences and their nuanced relationship with behavior change. Addiction.
Monico L, Ludwig A, Lertch E, Mitchell S (in press). Using timeline methodology to visualize treatment trajectories of youth and young adults following inpatient opioid treatment. International Journal of Qualitative Methods.
Gryczynski J, Mitchell SG, Schwartz RP, Kelly SM, Dušek K, Monico L, O’Grady KE, Brown BS, Oros M, Hosler C (2019). Disclosure of Adolescent Substance Use in Primary Care: Comparison of Routine Clinical Screening and Anonymous Research Interviews. Journal of Adolescent Health. 64(4):541-543. doi: 10.1016/j.jadohealth.2018.10.009. Epub 2018 Dec 18. PMID: 30578116.
Monico LB, Mitchell SG, Dusek K, Gryczynski J, Schwartz RP, Oros M, Hosler C, O’Grady KE, Brown BS (2019). A Comparison of Screening Practices for Adolescents in Primary Care After Implementation of Screening, Brief Intervention, and Referral to Treatment. Journal of Adolescent Health. Journal of Adolescent Health. 65(1):46-50. doi: 10.1016/j.jadohealth.2018.12.005. Epub 2019 Mar 6. PMID: 30850312.
Mitchell SG, Monico LB, Lertch E, Kelly SM, Gryczynski J, Jaffe J, O’Grady KE, & Schwartz RP (2018). Counseling staff's views of patient-centered methadone treatment: Changing program rules and staff roles. The Journal of Behavioral Health Services and Research. 45(3):506-515. doi: 10.1007/s11414-018-9603-1. PMID: 29536342.
Mitchell SG, Monico LB, Stitzer M, Matheson T, Sorensen JL, Feaster DJ, Schwartz RP, Metsch L (2018). How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment. Journal of Substance Abuse Treatment. 94:18-23. doi: 10.1016/j.jsat.2018.07.009. Epub 2018 Jul 22. PMID: 30243412.
Monico LB, Gryczynski J, Schwartz RP, Jaffe JH, O’Grady KE, & Mitchell SG (2018). Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12-months. The American Journal of Drug and Alcohol Abuse. 44(6):604-610. doi: 10.1080/00952990.2018.1461877. Epub 2018 May 2. PMID: 29718715.
Monico LB, Mitchell SG (2018). Patient perspectives on transitioning from prescription opioids to heroin and the role of route of administration. Substance Abuse Treatment, Prevention, and Policy. 13(1):4. doi: 10.1186/s13011-017-0137-y. PMID: 29378623.
Mitchell SG, Willett J, Monico LB, James A, Rudes DS, Viglioni J, Schwartz RP, Gordon MS, Friedmann PD (2016). Community Correctional Agents' Views of Medication-Assisted Treatment: Examining their Influence on Treatment Referrals and Community Supervision Practices. Substance Abuse. 37(1):127-33. doi: 10.1080/08897077.2015.1129389. PMID: 26860334. PMCID: PMC4823810.
Monico LB, Mitchell SG, Welsh W, Link N, Hamilton L, Malvini Redden S, Schwartz R, & Friedmann P (2016). Developing effective interorganizational relationships between community corrections and community treatment providers. Journal of Offender Rehabilitation.
Monico LB, Schwartz RP, Gryczynski J, O’Grady KE, & Mitchell SG (2016). Two models of integrating buprenorphine treatment and medical staff within formerly “drug-free” outpatient programs. Journal of Psychoactive Drugs.
Mitchell SG, Monico LB, Gryczynski J, O’Grady KE, Schwartz RP (2015). Staff Views of Acceptability and Appropriateness of a Computer-Delivered Brief Intervention for Moderate Drug and Alcohol Use. Journal of Psychoactive Drugs. 47(4):301-7. doi: 10.1080/02791072.2015.1075631. Epub 2015 Sep 16. PMID: 26375411.
Mitchell SG, Willett J, Swan H, Monico LB, Yang Y, Patterson Y, Belenko S, Vega-Debien Graciela Pankow J, Schwartz RP and Visher C (2015). Defining success: Insights from a random assignment, multi-site study of implementing HIV prevention, testing and linkage to care in US jails and prisons. AIDS Education and Prevention. 27(5):432-45. doi: 10.1521/aeap.2015.27.5.432. PMID: 26485233.
Monico LB, Abdel-Salam S, O’Connell D, Visher C, Martin S (2015). Using Organizational Strategies to Improve Substance Abuse Treatment for Probationers: A Case Study in Delaware. Federal Probation. Dec 2015.
Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O’Grady KE, Jaffe JH (2015). Buprenorphine treatment and 12-step meeting attendance: conflicts, compatibilities, and patient outcomes. Journal of Substance Abuse Treatment.   57:89-95. doi: 10.1016/j.jsat.2015.05.005. Epub 2015 May 12. PMID: 25986647.
Monico LB, Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2015). Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention. Journal of Substance Abuse Treatment. 57:57-62. doi: 10.1016/j.jsat.2015.04.010. Epub 2015 May 7. PMID: 25980599.
Welsh W, Prendergast M, Knight K, Knudsen H, Monico LB, Gray J, Abdel-Salam S, Malvini Redden S, Link N, Hamilton L, Shafer MS, Friedmann P (2015). Correlates of interorganizational service coordination in community corrections. Criminal Justice and Behavior. 43(4):483-505.
Welsh WN, Knudsen HK, Knight K, Ducharme L, Pankow J, Urbine T, Lindsey A, Abdel-Salam S, Wood J, Monico LB, Link N, Albizu-Garcia C, Friedmann PD (2015). Effects of an organizational linkage intervention on interorganizational service coordination between probation/parole agencies and community treatment providers. Administration and Policy in Mental Health Journal. 43(1):105-21.
Welsh WN, Lin H, Peters RH, Stahler GJ, Lehman WEK, Stein LAR, Monico LB, Eggers M, Abdel-Salam S, Pierce JC, Hunt E, Gallagher C, Frisman LK (2015). Effects of a strategy to improve offender assessment practices: Staff perceptions of implementation outcomes. Drug and Alcohol Dependence. 152:230-238.